| Literature DB >> 23383054 |
Eileen C Spindler1, Nanette R Boyle, Robert E W Hancock, Ryan T Gill.
Abstract
A fundamental issue in the design and development of antimicrobials is the lack of understanding of complex modes of action and how this complexity affects potential pathways for resistance evolution. Bac8c (RIWVIWRR-NH(2)) is an 8 amino acid antimicrobial peptide (AMP) that has been shown to have enhanced activity against a range of pathogenic Gram-positive and Gram-negative bacteria, as well as yeast. We have previously demonstrated that Bac8c appears to interfere with multiple targets, at least in part through the disruption of cytoplasmic membrane related functions, and that resistance to this peptide does not easily develop using standard laboratory methods. Here, we applied a genomics approach, SCalar Analysis of Library Enrichement (SCALEs), to map the effect of gene overexpression onto Bac8c resistance in parallel for all genes and gene combinations (up to ∼ 10 adjacent genes) in the E. coli genome (a total of ∼ 500,000 individual clones were mapped). Our efforts identified an elaborate network of genes for which overexpression leads to low-level resistance to Bac8c (including biofilm formation, multi-drug transporters, etc). This data was analyzed to provide insights into the complex relationships between mechanisms of action and potential routes by which resistance to this synthetic AMP can develop.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23383054 PMCID: PMC3561415 DOI: 10.1371/journal.pone.0055052
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Selection Design.
A) Strategy: unlike customary selections, our design decreases selective pressure (AMP concentration) through each successive batch. B) Histogram of each selected population displaying the increase in relative fitness over time through the three successive batches. C) Genome-wide plot of the multi-scale analysis of the fitness of each successive batch culture compared to the control culture at time 0. For each batch, the fitness for each 125-bp position is plotted around the genome for each scale referred to in the legend. A decrease in selective pressure (through each successive batch) moves outwards from the center circle. Circles i, ii, and iii correspond to the (6 µg/ml, 5 µg/ml, 4 µg/ml)/Control, (6 µg/ml, 5 µg/ml)/Control, and 6 µg/ml/Control, respectively. The percentage of the E. coli genome is plotted clockwise around the circles. Inserts with high fitness values are labeled. D) Growth of SCALEs selected clones. The specific growth of clones grown in 96 well plates and the OD600 taken every half hour for eight hours is plotted. Black bars indicate the specific growth of clones in the absence of Bac8c. White bars indicate the specific growth of the clones in the presence of Bac8c at a concentration equal to the IC50 of the control (3 µg/ml). The rpsLG-fusA, putA and yicJ clones all had an increased growth rate compared to the control strain in the presence of Bac8c at the IC50. *p-value<0.01 is for the white bars (IC50), t-test of control verses clones with resistance.
The MIC for each compound was determined after 18 h incubation at 37°C.
| Antibiotic | Mode of action | MIC (µg/ml) | ||||||||
| Control |
|
|
|
|
|
|
|
| ||
| Paraquat | electron donor | 100 | 20 | 20 | 100 | 5 | 40 | 100 | 60 | 40 |
| H202 | hydroxyl radical | 0.75 | 0.75 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CCCP | uncoupler | 25 | 50 | 50 | N/A | 50 | 50 | N/A | N/A | 50 |
| Polymyxin B | pore formation | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 1 | 0.5 | 0.5 | N/A |
| Vancomycin | cell membrane | <8 | <8 | <8 | >16 | <8 | <8 | <8 | <8 | N/A |
| Carbenicillin | cell wall synthesis | 2 | 4 | 4 | 2 | 4 | 4 | 2 | 2 | N/A |
| Gramicidin | pore formation | <8 | <8 | <8 | 32 | <8 | <8 | <8 | <8 | N/A |
| Streptomycin | protein synthesis | 64 | 64 | 64 | 64 | 64 | 64 | 32 | 64 | N/A |
| Bac2A | 8 | 8 | 8 | 64 | 8 | 8 | 64 | 8 | N/A | |
| Sub3 | 4 | 4 | 8 | 8 | 8 | 4 | 8 | 8 | N/A | |
| K24 | 4 | 8 | 8 | 8 | 8 | 4 | 8 | 4 | N/A | |
Results are shown for several antimicrobials with Control (Empty vector), and the vector with the cloned genes appBC (alternative terminal oxidase), lpd (lipoamide dehydrogenase), treBC (trehalose PTS permease), yajO (putative NAD(P)H-dependent xylose reductase), putA (proline dehydrogenase), rpsLG-fusA (elongation factor EF-Tu), yicJ (galactose-pentose-hexuronide transporter family), and dhaKLM (dihydroxyacetone kinase).